Abstract
Purpose. To characterize the ocular pharmacokinetics of beta-blockers (timolol and tilisolol) after instillation in the albino rabbit using a mathematical model that includes a diffusion process.
Methods. The disposition of fluorescein isothiocyanate-dextran (FITC-dextran, molecular weight 4400), timolol, and tilisolol was determined in tear fluid and aqueous humor after instillation or ocular injection in rabbits. The in vivo penetration parameters were estimated by fitting the concentration-time profiles to the Laplace equations based on a diffusion model using MULTI(FILT) program. Thein vivo permeability of drugs was measured across cornea using a two-chamber diffusion cell.
Results. Concentration-time profiles of drugs in the tear fluid after instillation showed a monoexponential curve. Although a monoexponential curve was observed in the aqueous humor concentration of FITC-dextran after injection into the aqueous chamber, timolol and tilisolol showed a biexponential curve. On the basis of these results, anin vivo pharmacokinetic model was developed for estimation of penetration parameters. The in vitro partition parameters were higher than those of the in vivo parameters.
Conclusions. The ocular absorption of timolol and tilisolol was characterized using an in vivo pharmacokinetic model and in vivo penetration parameters.
Similar content being viewed by others
REFERENCES
M. C. Makoid and J. R. Robinson. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye. J. Pharm. Sci. 68:435–443 (1979).
R. D. Schoenwald. Ocular drug delivery; pharmacokinetic considerations. Clin. Pharmacokinet. 18:255–269 (1990).
H. Sasaki, Y. Igarashi, K. Nishida, and J. Nakamura. Ocular delivery of the β-blocker, tilisolol, through the prodrug approach. Int. J. Pharm. 93:49–60 (1993).
H. Sasaki, Y. Igarashi, T. Nagano, K. Yamamura, K. Nishida, and J. Nakamura. Penetration of β-blockers through ocular membranes in albino rabbits. J. Pharm. Pharmacol. 47:17–21 (1995).
Y. Yano, K. Yamaoka, and H. Tanaka. A nonlinear least squares program, MULTI(FILT), based on fast inverse Laplace transform for microcomputers. Chem. Pharm. Bull. 37:1035–1038 (1989).
S. S. Chrai, T. F. Patton, A. Mehta, and J. R. Robinson. Lacrimal and instilled fluid dynamics in rabbit eyes. J. Pharm. Sci. 62:1112–1121 (1973).
M. G. Doane, A. D. Jensen, and C. H. Dohlman. Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 85:383–386 (1978).
J. M. Conrad and J. R. Robinson. Aqueous chamber drug distribution volume measurement in rabbits. J. Pharm. Sci. 66:219–224 (1977).
Y. Nakagawa, T. Sugai, W.-P. Chin, T. Shibuya, K. Hashimoto, and S. Imai. Pharmacological profile of a new β-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy-N-methylisocarbostyril hydrochloride (n-696). Arzneim.-Forsch./Drug Res. 34:194–199 (1984).
I. Ahmed, R. D. Gokhale, M. V. Shah, and T. F. Patton. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J. Pharm. Sci. 76:583–586 (1987).
S.-C. Chang, H. Bundgaard, A. Buur, and V. H. L. Lee. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest. Ophthalmol. Vis. Sci. 28:487–491 (1987).
H. Sasaki, K. Yamamura, C. Tei, K. Nishida, and J. Nakamura. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug. J. Drug Target. 3:129–135 (1995).
P. A. Zane, S. D. Brindle, D. O. Gause, A. J. O'Buck, P. R. Raghavan, and S. L. Tripp. Physicochemical factors associated with binding and retention of compounds in ocular melanin of rats; correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses. Pharm. Res. 7:935–941 (1990).
I. Ahmed, M. L. Francoeur, A. G. Thombre, and T. F. Patton. The kinetics of timolol in the rabbit lens; implications for ocular drug delivery. Pharm. Res. 6:772–778 (1989).
H. Miichi and S. Nagataki. Effects of cholinergic drugs and adrenergic drugs on aqueous humor formation in the rabbit eye. Jpn. J. Ophthalmol. 26:425–436 (1982).
M. Araie. Time change of rabbit aqueous flow under influence of adrenergic drugs. Exp. Eye Res. 40:391–403 (1985).
J. C. Keister, E. R. Cooper, P. J. Missel, J. C. Lang, and D. F. Hager. Limits on optimizing ocular drug delivery. J. Pharm. Sci. 80:50–53 (1991).
T. J. Mikkelson, S. S. Chrai, and J. R. Robinson. Altered bioavailability of drugs in the eye due to drug-protein interaction. J. Pharm. Sci. 62:1648–1653 (1973).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamamura, K., Sasaki, H., Nakashima, M. et al. Characterization of Ocular Pharmacokinetics of Beta-Blockers Using a Diffusion Model After Instillation. Pharm Res 16, 1596–1601 (1999). https://doi.org/10.1023/A:1018964823193
Issue Date:
DOI: https://doi.org/10.1023/A:1018964823193